麻豆传媒

Tommy Rennison is a Business Development Manager for the Northern Institute for Cancer Research, a joint position between the Faculty of Medical Sciences Enterprise Team and Cancer Research Technology Limited (the technology transfer arm of the charity Cancer Research UK), which he shares with Phil Elstob.

Roles and Responsibilities

Tommy and Phil are jointly responsible for a strategic alliance between the University and Cancer Research Technology that focuses on the identification, protection, development and commercialisation of novel cancer technologies. Specific activities include:

·         Sourcing and evaluating potential new projects (cancer therapies and diagnostics/prognostics)

·         Identifying/securing funding for and managing the development of cancer technologies (mainly small molecule drug   discovery projects)

·         Intellectual property assessment (patentability and freedom to operate), patent filing and prosecution

·         Developing and delivering marketing and commercialisation strategies

·         Structuring, negotiation and execution of a wide range of intellectual property agreements, and the use of financial models for deal valuation

• Harnor SJ, Rennison T, Galler M, Cano C, Griffin RJ, Newell DR, Golding BT. . MedChemComm 2014, 5(7), 984-988.
• Barrett L, Rennison T, Clapham KM, Rodriguez-Aristegui S, Bardos J, Curtin NJ, Dennis M, Finlay R, Golding BT, Hardcastle IR, Newell DR, Young G, Cano C, Griffin RJ. . In: 245th ACS National Meeting and Exposition. 2013, New Orleans, Louisiana: American Chemical Society.
• Haagensen EJ, Thomas HD, Wilson I, Harnor SJ, Payne SL, Rennison T, Smith KM, Maxwell RJ, Newell DR. . PLoS ONE 2013, 8(12), e81763.